COVID swap being inserted into vial But dogged by issues of cost, access, logistics andemployee privacy, tests aren't part of most back-to-workplans.(Photo: Shutterstock)

(Bloomberg) –From nursing homes in New York and a landfill inUtah to Disney World and the Las Vegas Strip, employers arewrestling with workplace safety in the age of Covid-19 and makingfraught calculations about how to safeguard both their businessesand their employees. Mass testing, a critical tool to stem thevirus's spread, would appear an obvious solution.

But dogged by issues of cost — diagnostic tests start at around$100 each — access, logistics and employee privacy, tests aren'tpart of most back-to-work plans. As health-care companies that workwith employers in this capacity are fond of saying, there's nosilver bullet.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Compliance
Employer-Paid